Annals of Colorectal Research

Published by: Kowsar

Liver Transplantation for Non-Resectable Colorectal Liver Metastases

Ashwin Rammohan 1 , *
Author Information
1 Institute of Liver Disease & Transplantation, Dr.Rela Institute & Medical Centre, Chennai, India
Article information
  • Annals of Colorectal Research: December 31, 2018, 6 (4); e83855
  • Published Online: October 9, 2018
  • Article Type: Brief Report
  • Received: September 2, 2018
  • Accepted: October 1, 2018
  • DOI: 10.5812/acr.83855

To Cite: Rammohan A. Liver Transplantation for Non-Resectable Colorectal Liver Metastases, Ann Colorectal Res. 2018 ; 6(4):e83855. doi: 10.5812/acr.83855.

Copyright © 2018, Annals of Colorectal Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Results of LT for NCRLM
3. The Future & Ethical Considerations
4. Conclusion
  • 1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917. doi: 10.1002/ijc.25516. [PubMed: 21351269].
  • 2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10-29. doi: 10.3322/caac.20138. [PubMed: 22237781].
  • 3. Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: Expert consensus statement. Ann Surg Oncol. 2006;13(10):1271-80. doi: 10.1245/s10434-006-9045-5. [PubMed: 16955381].
  • 4. de Haas RJ, Wicherts DA, Andreani P, Pascal G, Saliba F, Ichai P, et al. Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection. Ann Surg. 2011;253(6):1069-79. doi: 10.1097/SLA.0b013e318217e898. [PubMed: 21451388].
  • 5. Saiura A, Yamamoto J, Koga R, Takahashi Y, Takahashi M, Inoue Y, et al. Favorable outcome after repeat resection for colorectal liver metastases. Ann Surg Oncol. 2014;21(13):4293-9. doi: 10.1245/s10434-014-3863-7. [PubMed: 24962942].
  • 6. House MG, Ito H, Gonen M, Fong Y, Allen PJ, DeMatteo RP, et al. Survival after hepatic resection for metastatic colorectal cancer: Trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg. 2010;210(5):744-52. 752-5. doi: 10.1016/j.jamcollsurg.2009.12.040. [PubMed: 20421043].
  • 7. Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, et al. Survival after liver resection in metastatic colorectal cancer: Review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283-301. doi: 10.2147/CLEP.S34285. [PubMed: 23152705]. [PubMed Central: PMC3496330].
  • 8. Muhlbacher F, Huk I, Steininger R, Gnant M, Gotzinger P, Wamser P, et al. Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver? Transplant Proc. 1991;23(1 Pt 2):1567-8. [PubMed: 1989293].
  • 9. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery. 1991;110(4):726-34. discussion 734-5. [PubMed: 1656538].
  • 10. Hoti E, Adam R. Liver transplantation for primary and metastatic liver cancers. Transpl Int. 2008;21(12):1107-17. doi: 10.1111/j.1432-2277.2008.00735.x. [PubMed: 18713148].
  • 11. Hagness M, Foss A, Line PD, Scholz T, Jorgensen PF, Fosby B, et al. Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg. 2013;257(5):800-6. doi: 10.1097/SLA.0b013e3182823957. [PubMed: 23360920].
  • 12. Dueland S, Guren TK, Hagness M, Glimelius B, Line PD, Pfeiffer P, et al. Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer? Ann Surg. 2015;261(5):956-60. doi: 10.1097/SLA.0000000000000786. [PubMed: 24950280].
  • 13. Tveit KM, Guren T, Glimelius B, Pfeiffer P, Sorbye H, Pyrhonen S, et al. Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: The NORDIC-VII study. J Clin Oncol. 2012;30(15):1755-62. doi: 10.1200/JCO.2011.38.0915. [PubMed: 22473155].
  • 14. Toso C, Pinto Marques H, Andres A, Castro Sousa F, Adam R, Kalil A, et al. Liver transplantation for colorectal liver metastasis: Survival without recurrence can be achieved. Liver Transpl. 2017;23(8):1073-6. doi: 10.1002/lt.24791. [PubMed: 28544246].
  • 15. Chua TC, Liauw W, Chu F, Morris DL. Viewing metastatic colorectal cancer as a curable chronic disease. Am J Clin Oncol. 2012;35(1):77-80. doi: 10.1097/COC.0b013e3181fe4444. [PubMed: 22257778].
  • 16. Bethesda (MD): National Library of Medicine (US) . A randomized controlled clinical trial to evaluate the benefit and efficacy of liver transplantation as treatment for selected patients with liver metastases from colorectal carcinoma. 2011, [cited 2018 Sep 02]. Available from:
  • 17. Bethesda (MD): National Library of Medicine (US) . A Phase I/II clinical trial to evaluate the benefit and efficacy of liver resection and partial liver segment 2/3 transplantation with delayed total hepatectomy as treatment for selected patients with liver metastases from colorectal carcinoma. 2014, [cited 2018 Sep 02]. Available from:
  • 18. Line PD, Hagness M, Berstad AE, Foss A, Dueland S. A novel concept for partial liver transplantation in nonresectable colorectal liver metastases: The RAPID concept. Ann Surg. 2015;262(1):e5-9. doi: 10.1097/SLA.0000000000001165. [PubMed: 25692361].
  • 19. Bethesda (MD): National Library of Medicine (US) . Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy (TRANSMET). 2015, [cited 2018 Sep 02]. Available from:
  • 20. Pomfret EA, Lodge JP, Villamil FG, Siegler M. Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations. Liver Transpl. 2011;17 Suppl 2:S128-32. doi: 10.1002/lt.22356. [PubMed: 21656657].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments